Valion Bio, Inc. Accounts Payable
Valion Bio, Inc. (VBIO) had Accounts Payable of $639.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable, Current $639.00K.
- 2026-03-31: Accounts Payable, Current $629.00K.
- 2025-12-31: Accounts Payable, Current $264.00K.
- 2025-09-30: Accounts Payable, Current $465.00K.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $639.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $629.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $264.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $465.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $234.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $438.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $125.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $333.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $446.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $547.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $713.00K 10-K · filed 2025-03-21 |
| 2023-09-30 | $638.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $831.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.09M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.32M 10-K · filed 2024-03-25 |
| 2022-09-30 | $1.60M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.92M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $625.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $789.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |